Company Search:
Advanced Search
Sponsored Links
ArQule, Inc. Company Snapshot
ArQule, Inc. operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares ArQule with three other companies in this sector in the United States: Aeglea Bio Therapeutics Inc (2016 sales of $4.63 million of which 100% was Pharmaceutical), Acura Pharmaceuticals, Inc. ($4.46 million of which 100% was Generic Drug Products), and Innovus Pharmaceuticals Inc ($4.82 million ).

Sales Analysis. During the year ended December of 2016, sales at ArQule were $4.71 million. This is a sharp decrease of 58.1% versus 2015, when the company's sales were $11.24 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
ArQule, Inc.
  Stock Performance Chart for ArQule, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (11/17/2017): 1.42
(Figures in U.S. Dollars)
1 Week 17.4%   13 Weeks 27.9%  
4 Weeks 37.9%   52 Weeks 1.4%  
ArQule, Inc. Key Data:
  Ticker: ARQL Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 4,709,000
(Year Ending Jan 2017).
Employees: 36
  Currency: U.S. Dollars Market Cap: 103,903,602
  Fiscal Yr Ends: December Shares Outstanding: 73,171,551
  Share Type: Common Closely Held Shares: 8,328,548
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.